Genprex, Inc. — Director's Dealing 2018

Mar 29, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Genprex, Inc. (GNPX)
CIK: 0001595248
Period of Report: 2018-03-28

Reporting Person: Varner John Rodney (Director, Chief Executive Officer, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	534735	Direct
Common Stock	1614152	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$.96	2026-04-11	Common Stock (645572)		Direct

Footnotes

F1: Fully vested.